SEC 13F Intelligence

Managers / Q1 2024 · view latest →

HighVista Strategies LLC

CIK 0001335325 · 200 CLARENDON STREET, 50TH FLOOR, BOSTON, MA, 02116 · 617-406-6500

Reported Value
$280M
Q1 2024
Positions
131
Filings on Record
30
2019–present window
Filed
May 15, 2024
original filing

Summary

Highvista Strategies LLC reported $280M in U.S.-listed holdings across 131 positions for Q1 2024.

Its largest position, DBC, represents 11.8% of the portfolio.

Compared with Q4 2023, the fund opened 40 new positions and exited 35.

Portfolio Metrics

Turnover
+30.2%
vs prior filed quarter
Top-10 Concentration
+28.7%
share of reported value
Largest Position
+11.8%
Invesco Db Commdy Indx Trck
New / Exited
40 / 35
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $116MQ4 ’18Q1 ’19: $123MQ2 ’19: $195MQ3 ’19: $147MQ4 ’19: $132MQ4 ’19Q1 ’20: $108MQ2 ’20: $121MQ3 ’20: $137MQ4 ’20: $157MQ4 ’20Q1 ’21: $135MQ2 ’21: $141MQ3 ’21: $151MQ4 ’21: $126MQ4 ’21Q1 ’22: $157MQ2 ’22: $166MQ3 ’22: $175MQ4 ’22: $168MQ4 ’22Q1 ’23: $123MQ2 ’23: $219MQ3 ’23: $216MQ4 ’23: $276MQ4 ’23Q1 ’24: $280MQ2 ’24: $274MQ3 ’24: $290MQ4 ’24: $269MQ4 ’24Q1 ’25: $260MQ2 ’25: $272MQ3 ’25: $408MQ4 ’25: $388MQ4 ’25Q1 ’26: $362Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 67.3%ETP: 12.8%ADR: 10.2%Other: 8.7%REIT: 1.0%
  • Common Stock · 67.3% · $189M
  • ETP · 12.8% · $36M
  • ADR · 10.2% · $29M
  • Other · 8.7% · $24M
  • REIT · 1.0% · $3M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
APGEAPOGEE THERAPEUTICS INCNEW+119.4K119.4K+$8M$8M
AKXANSYS INCNEW+12.8K12.8K+$4M$4M
JNPJUNIPER NETWORKS INCNEW+114.7K114.7K+$4M$4M
VANECK ETF TRUSTNEW+87.8K87.8K+$3M$3M
KROSKEROS THERAPEUTICS INCNEW+39.2K39.2K+$3M$3M
SWTXUSDSPRINGWORKS THERAPEUTICS INCNEW+51.0K51.0K+$3M$3M
OFIXORTHOFIX MED INCNEW+167.9K167.9K+$2M$2M
CARTMAPLEBEAR INCNEW+62.4K62.4K+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2024

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1DBCINVESCO DB COMMDY INDX TRCKhistory →UNIT11.76%$33M1.44M
2APGEAPOGEE THERAPEUTICS INChistory →COM2.83%$8M119.4K
3SYRESPYRE THERAPEUTICS INChistory →COM NEW2.09%$6M154.4K
4MERUS N VCOM1.95%$5M121.7K
5MSFTMICROSOFT CORPhistory →COM1.84%$5M12.3K
6ACLXGBXARCELLX INChistory →COMMON STOCK1.79%$5M72.2K
7XPOXPO INChistory →COM1.67%$5M38.4K
8NUVLNUVALENT INChistory →COM1.61%$5M60.0K
9AKXANSYS INChistory →COM1.58%$4M12.8K
10HESHESS CORPhistory →COM1.57%$4M28.9K
11IDYAIDEAYA BIOSCIENCES INChistory →COM1.55%$4M99.3K
12JNPJUNIPER NETWORKS INChistory →COM1.52%$4M114.7K
13SP PLUS CORPCOM1.47%$4M78.9K
14CEREVEL THERAPEUTICS HLDNG ICOM1.47%$4M97.2K
15ACIALBERTSONS COS INChistory →COMMON STOCK1.44%$4M188.8K
16BCYCBICYCLE THERAPEUTICS PLChistory →SPONSORED ADS1.41%$4M158.3K
17AXSMAXSOME THERAPEUTICS INChistory →COM1.38%$4M48.5K
18INDIVIOR PLCORD1.36%$4M178.8K
19CRMSALESFORCE INChistory →COM1.36%$4M12.7K
20AMZNAMAZON COM INChistory →COM1.29%$4M20.1K
21AMEDAMEDISYS INChistory →COM1.29%$4M39.3K
22CAPRI HOLDINGS LIMITEDSHS1.26%$4M77.7K
23VRDNVIRIDIAN THERAPEUTICS INChistory →COM1.24%$3M198.5K
24IM8NINSMED INChistory →COM PAR $.011.23%$3M126.8K
25XENEXENON PHARMACEUTICALS INChistory →COM1.12%$3M72.7K
26MLTXMOONLAKE IMMUNOTHERAPEUTICShistory →CLASS A ORD1.07%$3M59.8K
27RTXRTX CORPORATIONhistory →COM1.05%$3M30.3K
28X0M1XOMA CORP DELhistory →COM NEW1.02%$3M118.9K
29OLMAOLEMA PHARMACEUTICALS INChistory →COM1.00%$3M247.9K
30VANECK ETF TRUSTGOLD MINERS ETF0.99%$3M87.8K
31BKNGBOOKING HOLDINGS INCCOM0.98%$3M757
32ARGXARGENX SESPONSORED ADR0.95%$3M6.7K
33KROSKEROS THERAPEUTICS INCCOM0.93%$3M39.2K
34SWTXUSDSPRINGWORKS THERAPEUTICS INCCOM0.89%$3M51.0K
35VVISA INCCOM CL A0.89%$2M8.9K
36OFIXORTHOFIX MED INCCOM0.87%$2M167.9K
37WCCWESCO INTL INCCOM0.87%$2M14.2K
38LAURLAUREATE EDUCATION INCCOMMON STOCK0.85%$2M163.5K
39CARTMAPLEBEAR INCCOM0.83%$2M62.4K
4037MMRC GLOBAL INCCOM0.81%$2M180.4K
41IMCRIMMUNOCORE HLDGS PLCADS0.81%$2M34.8K
42ROIVANT SCIENCES LTDSHS0.80%$2M212.1K
43ELVNENLIVEN THERAPEUTICS INCCOM0.80%$2M126.9K
44METAMETA PLATFORMS INCCL A0.78%$2M4.5K
45ARVNARVINAS INCCOM0.75%$2M51.1K
46LEGNLEGEND BIOTECH CORPSPONSORED ADS0.73%$2M36.4K
47FISVFISERV INCCOM0.72%$2M12.7K
48DVAXDYNAVAX TECHNOLOGIES CORPCOM NEW0.69%$2M156.2K
49INTUINTUITCOM0.69%$2M3.0K
50LADLITHIA MTRS INCCOM0.69%$2M6.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$362M156May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$388M145Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$408M148Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$272M146Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$260M148May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$269M137Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$290M142Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$274M138Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$280M131May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$276M126Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$216M132Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$219M134Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$123M108May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$168M105Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$175M113Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$166M110Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$157M86May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$126M69Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$151M127Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$141M116Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$135M125May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$157M117Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$137M113Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$121M100Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$108M65May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$132M119Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$147M126Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$195M108Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$123M112May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$116M113Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • HighVista Private Capital Management LLC

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.